Advances in composite tissue allograft transplantation as related to the hand and upper extremity

Journal of Hand Surgery

Volumn 27, Issue 4, 2002, Pages 565-580

  Siemionow, Maria ^a   Ozer, Kagan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Composite tissue allograft; Immunosuppression; Tolerance

Indexed keywords

15 DEOXYSPERGUALIN; AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE ACETATE; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOTRANSPLANTATION; ARM; CLINICAL RESEARCH; COMPOSITE GRAFT; GRAFT REJECTION; HAND SURGERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRANSPLANTATION TOLERANCE;

EID: 0036067930     PISSN: 03635023     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhsu.2002.34367     Document Type: Article

References (125)

1. Cosmas and Damien revisited
2. The sympathetic slave
3. Results of the transplantation of blood vessels, organs and limbs
4. Essai sur la greffe des tissues articularie
5. Substitution of whole or half joints from freshly amputated extremities by free plastic operation
6. The full-thickness skin graft in the correction of soft tissue deformities
7. Successful transplantation of a leg in albino rats with reestablishment of muscular control
8. Homotransplantation by parabiosis
9. Homotransplantation of extremities of rats
10. The fate of skin homografts in man
11. Homotransplantation of extremities in tolerant dogs observed up to seven years
12. 'Actively acquired tolerance' of foreign cells
13. Canine limb homotransplantation
14. Transplantation of the canine hind limb. Surgical technique and methods of immunosuppression for allotransplantation - A preliminary report
15. Transplant is successful with a cadaver forearm
16. Studies of vascularised homotransplants of the knee joint
17. Biological effects of Cyclosporine A: A new antilymphocytic agent
18. Cosmas and Damian in the laboratory
19. Cyclosporin-A (CyA) is superior to prior donor-specific blood (DSB) transfusion for the extensive prolongation of rat limb allograft survival
20. Diagnosis of rejection and functional analysis of composite tissue (CT) and skin allografts prolonged with cyclosporine
21. Composite tissue (limb) allografts in rats. I. Dose-dependent increase in survival with cyclosporine
22. Composite tissue (limb) allografts in rats. II. Indefinite survival using low-dose cyclosporine
23. Composite tissue (limb) allografts in rats. III. Development of donor-host lymphoid chimeras in long-term survivors
24. The peripheral nerve allograft: An assessment of regeneration in the immunosuppressed host
25. Clinical outcome following nerve allograft transplantation
26. Human allotransplant of a digital flexion system vascularized on the ulnar side pedicle: A preliminary report and 1-year follow-up of two cases
27. Clinical experience in allogeneic vascularized bone and joint allografting
28. Allogeneic vascularized grafting of human knee joints under postoperative immunosuppression of the recipient
29. Transplantation of vascularized allogeneic skeletal muscle for scalp reconstruction in a renal transplant patient
30. Special feature: Current state of laryngeal transplantation
31. Human hand allograft: Report on first 6 months
32. Successful hand transplantation. One-year follow-up
33. Hand transplantation: Comparisons and observations of the first four clinical cases
34. Transplantation of hands in Innsbruck
35. Transplantation immunology
36. Contribution of direct and indirect recognition pathways to T cell alloreactivity
37. Mechanisms of T cell recognition of alloantigen. The role of peptides
38. + cells are essential for allorejection
39. New immunosuppressives and clinical studies: An embarrassment of riches or more toxicity management?
40. Relative antigenicity of components of a vascularized limb allograft
41. Limb allotransplantation in the rat: Extended survival and return of nerve function with continuous cyclosporin/prednisone immunosuppression
42. The effect of combined immunosuppression with systemic low-dose cyclosporin and topical fluocinolone acetonide on the survival of rat hind-limb allografts
43. Limb allografts in rats immunosuppressed with FK506: I. Reversal of rejection and indefinite survival
44. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine
45. Use of combination of low-dose cyclosporine and RS-61443 in a rat hindlimb model of composite tissue allotransplantation
46. Limb allotransplantation in rats: Combined immunosuppression by FK-506 and deoxyspergualin
47. Long-term composite tissue allograft survival in a porcine model with cyclosporine/mycophenolate mofetil therapy
48. Use of swine model in transplantation of vascularized skeletal tissue allografts
49. Tolerance to limb tissue allografts between swine matched for major histocompatibility complex antigens
50. Localization of class II MHC antigens on porcine renal vascular endothelium
51. Tissue transplants in primates for upper extremity reconstruction: A preliminary report
52. Hand transplantation in baboons
53. Allogeneic transplantation of the radial side of the hand in the rhesus monkey: I. Technical aspects
54. Cyclosporine
55. Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation
56. Mycophenolate mofetil
57. Immunosuppression in organ transplantation
58. Strategies for developing organ transplant tolerance
59. Successful transfer of immune unresponsiveness to concordant rat islet xenografts
60. The lost chord: Microchimerism and allograft survival
61. Induction of tolerance to islet xenografts in concordant rat-to-mouse model
62. Split tolerance in spleen chimeras
63. Immunogenetic consequences of vascular anastomoses between bovine twins
64. Developmental biology of T cell receptors
65. Structure and function of the T cell antigen receptor
66. T-cell development and transmembrane signaling: Changing biological responses through an unchanging receptor
67. Diversity and structure of genes of the a family of mouse T-cell antigen receptor
68. Towards an integrated view of thymopoiesis
69. Costimulation of T lymphocytes: The role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy
70. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering
71. Anergic T cells as suppressor cells in vitro
72. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue
73. T cell tolerance by clonal elimination in the thymus
74. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance
75. Role of peripheral clonal deletion in tolerance induction with bone marrow transplantation and costimulatory blockade
76. Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions
77. Analysis of chronic rejection and obliterative arteriopathy. Possible contributions of donor antigen-presenting cells and lymphatic disruption
78. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown Norway rats
79. Induction of immunity and oral tolerance with polymorphic class II major histocompatibility complex allopeptides in the rat
80. Prolongation of allogeneic heart allograft survival in rats by administration of a peptide (a.a. 75-84) from the α1 helix of the first domain of HLA-B7 01
81. Cellular basis of long-term organ transplant acceptance: Pivotal role of intrathymic clonal deletion and thymic dependence of bone marrow microchimerism-associated tolerance
82. Adhesion receptors of the immune system
83. Combination of anti-ICAM-1 and anti-LFA-1 monoclonal antibody therapy prolongs allograft survival in rat hind limb transplants
84. Mechanisms maintaining transplantation tolerance in antithymocyte globulin-treated rats
85. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
86. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy
87. Anti-CD4 monoclonal antibodies in therapy: Creation of nonclassical tolerance in the adult
88. Cellular basis of allograft rejection in vivo. V. Examination of the mechanisms responsible for the differing efficacy of monoclonal antibody to CD4+ T cell subsets in low- and high-responder rat strains
89. α/β-T Cell receptor-directed therapy in rat cardiac allograft recipients. Treatment prior to alloantigen exposure prevents sensitization and abrogates accelerated rejection
90. A new model for induction of tolerance in composite tissue allografts-combined limb-thymus transplantation
91. The role of T-cell costimulatory activation pathways in transplant rejection
92. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated-murine cardiac allograft recipients
93. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor-specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism
94. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
95. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
96. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner
97. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
98. Cell migration, chimerism, and graft acceptance
99. Patterns of donor-type microchimerism after heart transplantation
100. Status of microchimerism in recipients 15 years after living related kidney transplantation
101. Fast lymphoid reconstitution after vascularized bone marrow transplantation in lethally irradiated rats
102. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vivo
103. Prevention of autoimmune inflammatory polyarthritis in male New Zealand black/KN mice by transplantation of bone marrow cells plus bone (stromal cells)
104. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-lpr/lpr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor
105. 3 integrin-mediated adhesion and migration of human hematopoietic progenitor cells
106. Interleukin-7Rα mRNA expression increases as stem cells differentiate into T and B lymphocyte progenitors
107. Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31)
108. Cytokines in T-cell development
109. Cytokine receptor expression on hematopoietic stem and progenitor cells
110. Structural and functional characterization of osteogenic growth peptide from human serum: Identity with rat and mouse homologs
111. Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice
112. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells
113. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts
114. Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen
115. Assessment of thymic output in adults after hematopoietic stem-cell transplantation and prediction of T-cell reconstitution
116. Mixed chimerism and tolerance without whole body irradiation in a large animal model
117. Intracoronary gene transfer of immunosuppressive cytokines to cardiac allografts: Method and efficacy of adenovirus-mediated transduction
118. Adenovirus-mediated gene transfer in the transplant setting. Early events after orthotopic transplantation of liver allografts expressing TGF-β1
119. Role of the thymus in donor specific hyporesponsiveness induced by retroviral transduction of bone marrow using an MHC class I gene
120. Frequent achievement of a drug-free state after orthotopic liver transplantation
121. Immunologic tolerance to renal allografts after bone marrow transplants from the same donors
122. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor
123. Transplantation of a lobe of lung from mother to child following previous transplantation with maternal bone marrow
124. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end-stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism